Search Within

Heiko Schoder

  1. "CTCR Scholars"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (14)
  3. Research Letter (1)
Groups
  1. CTCR Scholars (32)
  2. Molecular Imaging and Therapy Service (32)
  3. Radiology, Department of (32)
  4. Department of Medicine (31)
  5. Sloan Kettering Institute Postdocs (30)
  6. Center for Hematologic Malignancies (27)

More Groups

People
  1. Maria Palomba (21)
  2. Gilles Salles (18)
  3. Gunjan Shah (16)
  4. Miguel-Angel Perales (16)
  5. Parastoo Dahi (15)
  6. Michael Scordo (14)

More People

Years
  1. 2025 (5)
  2. 2024 (5)
  3. 2023 (6)
  4. 2022 (3)
  5. 2021 (6)
  6. 2020 (3)

More Years

Publications
  1. Blood (9)
  2. Hematological Oncology (3)
  3. International Journal of Radiation Oncology, Biology, Physics (3)
  4. Journal of Clinical Oncology (3)
  5. Blood Cancer Journal (2)
  6. Bone Marrow Transplantation (2)

More Publications

Publishers
  1. American Society of Hematology (10)
  2. Nature Publishing Group (5)
  3. Elsevier Inc. (4)
  4. American Society of Clinical Oncology (3)
  5. Wiley Blackwell (3)
  6. Taylor & Francis Group (2)

More Publishers

Results (32)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interim efficacy analysis of a phase II study demonstrates promising activity of the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S.; Biggar, E.; Moskowitz, A. J.; Joffe, E.; Khan, N.; Straus, D. J.; Kumar, A.; Zelenetz, A. D.; Horwitz, S. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Favorable outcomes of patients with limited-stage ocular adnexal DLBCL treated in the rituximab era: Long-term follow-up of a single center experience
    Meeting Abstract

    Qualls, D.; Batlevi, C. L.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Khan, N.; Kumar, A.; Matasar, M. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Outcomes of adult T-cell leukemia/lymphoma with allogeneic stem cell transplantation: Single-institution experience
    Journal Article

    Epstein-Peterson, Z. D.; Ganesan, N.; Barker, J. N.; Drullinsky, P. R.; Ghione, P.; Jakubowski, A. A.; Kumar, A.; Moskowitz, A. J.; Noy, A.; Perales, M. A.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Clinical outcomes and the role of observation in early‐stage follicular lymphoma
    Meeting Abstract

    Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Kumar, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Phase II study of pembrolizumab plus GVD as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Hancock, H.; Davey, T.; Sohail, S.; Santarosa, A.; Pomerantz, L.; Jarjies, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Impact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma
    Research Letter

    Lin, R. J.; Ho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Shah, G. L.; Perales, M. A.; Dahi, P. B.; Giralt, S. A.; Scordo, M.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients
    Journal Article

    Lin, R. J.; Michaud, L.; Lobaugh, S. M.; Nakajima, R.; Mauguen, A.; Elko, T. A.; Ruiz, J. D.; Maloy, M. A.; Sauter, C. S.; Dahi, P. B.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Retrospective analysis of gemcitabine and oxaliplatin (GemOx)-based treatment in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
    Meeting Abstract

    Schade, J. R.; Kim, C.; Drill, E.; Qiu, A.; Batlevi, C. L.; Caron, P.; Colbourn, D. S.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • High complete response rate observed with second-line chemo-immunotherapy with pembrolizumab and GVD (gemcitabine, vinorelbine, and liposomal doxorubicin) in relapsed and refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G. L.; Schoder, H.; Hancock, H.; Davey, T.; Joong, C.; Pomerantz, L.; Jarjies, C.; Kumar, A.; Lahoud, O. B.; more...
    Blood (2019)

    Fulltext@MSK | Save